QuidelOrtho appoints John Chiminski and Scott Huennekens as independent directors

QuidelOrtho Corp

Appointments effective December 6, 2024; both qualify as independent under Nasdaq rules.
Chiminski served as CEO of Catalent (CTLT) from 2009-2022; Huennekens was CEO of Volcano Corporation.
Replace James Prutow and Robert Schmidt who resigned Nov 21, 2024 related to Carlyle secondary offering.
Board expands to 11 directors, 10 independent, following a search led by Nominating Committee.
New directors bring MedTech and diagnostics expertise; no family relationships or material transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.